You are here

Clinical and Applied Thrombosis/Hemostasis

Clinical and Applied Thrombosis/Hemostasis

2017 Impact Factor: 1.852
2017 Ranking: 52/71 in Hematology | 46/65 in Peripheral Vascular Disease
Source: Journal Citation Reports®, 2018 release, a Clarivate Analytics product; Indexed in PubMed: MEDLINE; Indexed in PubMed Central

Editor
Charles A. Carter, PharmD, MBA Campbell University, Buies Creek, NC, USA


eISSN: 19382723 | ISSN: 10760296 | Current volume: 24 | Current issue: 7

Journal Highlights

  • Impact Factor: 1.852
  • Indexed In: Clarivate Analytics: Science Citation Index, PubMed/MEDLINE, PubMed Central
  • Publication is subject to payment of an article processing charge (APC)
  • Submit here

Clinical and Applied Thrombosis/Hemostasis (CATH) is a peer-reviewed open access journal which focuses on the practical clinical and laboratory issues involved in managing bleeding and clotting disorders, especially those related to thrombosis, hemostasis, and vascular disorders. Please see the Aims and Scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).


Submission information

Submit your manuscript today at https://mc.manuscriptcentral.com/cath.

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.


Open access article processing charge (APC) information

Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license.

The APC for this journal is currently an introductory rate of $1000 USD discounted from the full rate of $2000 USD. This introductory rate is available for a limited time.

The article processing charge (APC) is payable only if your article is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.

Contact

Please direct any queries to sheilaplatt@optonline.net.

Other information

This journal changed its publication mode from subscription to open access in 2018.



 

Clinical and Applied Thrombosis/Hemostasis (CATH) is an open access, peer reviewed journal which is dedicated to serving as a forum for studies regarding the etiology, pathophysiology, clinical diagnosis, laboratory diagnosis, and treatment of thrombohemorrhagic disorders.
 
Articles dealing with new diagnostic procedures are encouraged, provided they are clinically oriented or potentially applicable to clinical and laboratory medicine. Articles dealing with all aspects of thrombosis, hemostasis, and vascular disorders of clinical or clinical laboratory applicability are also encouraged. The contents of the journal appeal to any person interested in clinical and applied thrombohemorrhagic disorders.

Managing Editor
Senior Editors
William Baker, Jr. MD, FACP  
Jawed Fareed, Ph.D Loyola University Chicago, USA
Esteban Gandara The Ottowa Hospital, General Campus, Canada
Deborah Hoppensteadt, Ph.D Loyola University Chicago, USA
Evi Kalodiki Ealing Hospital, UK
Nicos Labropoulos Stony Brook University Medical Center, USA
Qing Ma New York University at Buffalo, Buffalo, NY, USA
Graham Pineo, M.D. University of Calgary, Canada
Jeanine M. Walenga, Ph.D Loyola University Medical Center, Maywood, IL, USA
Senior European Editors
Antonio Girolami, M.D. University of Padua, Italy
Sylvia Haas, MD Munich, Germany
Walter Jeske, Ph.D Loyola University Medical Center, Maywood, IL, USA
Wolfgang Miesbach Universitätsklinikum Frankfurt, Germany
Hideo Wada, M.D. Mie University, Japan
Mediterranean Editor
Muzaffer Demir, M.D. Trakya University, Turkey
Editorial Board Members
Raul Altman, M.D. Buenos Aires, Argentina
H. Peter Bacher, M.D., Ph.D Long Grove, IL, USA
Gianni Belcaro, M.D., Ph.D Pelcara, Italy
Samuel Berkman, M.D., FACP Bevery Hills, CA, USA
Anthony K. Chan McMaster University, Canada
Sergio Coccheri Bologna, Italy
Charles J. Glueck, M.D. Cholesterol Center, ABC Building
Lothar Heilmann Russelheim, Germany
Joseph Heissler, Jr., Pharm.D Pfizer Global Pharmaceuticals, USA
Mohammad Jamshidi, DO, FACS Millennia Care Clinic, TX, USA
Valery Leytin, Ph.D St. Michael’s Hospital, Toronto, Canada
Dimitri P. Mikhailidis, M.D., FRCPATH Royal Free and University College Medical School, UK
Michael Mosesson, M.D. University of Wisconsin, USA
Bali Netaji, M.D. Southwest Regional Cancer Center, Australia
Andrew N. Nicolaides  
William F. Pope Dallas, TX, USA
Alice Runge, M.T. Santa Monica, CA, USA
Arthur Sasahara, M.D. Boston, MA, USA
Renu Saxena  
Georg-Friedrich von Tempelhoff, M.D. City Hospital of Ruesselshein, Germany
Oran Ulutin, M.D. Istanbul, Turkey
David H. Van Thiel, M.D.  
James Wilson, M.D. Texas Medical Center, USA
Emeritus Editor
  • Clarivate Analytics: Current Contents - Clinical Medicine
  • Clarivate Analytics: Science Citation Index (SCI)
  • EMBASE/Excerpta Medica
  • Inpharma Database
  • MEDLINE
  • Ovid: Allied and Complementary Medicine Database
  • Reactions Database
  • SciSearch
  • Science Citation Index Expanded (Web of Science)
  • This Journal is a member of the Committee on Publication Ethics.

    This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing,
    and Publication of Scholarly Work in Medical Journals
    formulated by the International Committee of
    Medical Journal Editors (ICMJE).

    Please read the guidelines below then visit the journal’s submission site
    https://mc.manuscriptcentral.com/cath to upload your manuscript. Please note that manuscripts not
    conforming to these guidelines may be returned.

    Only manuscripts of sufficient quality that meet the aims and scope of Clinical and Applied
    Thrombosis/Hemostasis
    will be reviewed.

    As part of the submission process you will be required to warrant that you are submitting your original
    work, that you have the rights in the work, that you are submitting the work for first publication in the
    Journal and that it is not being considered for publication elsewhere and has not already been published
    elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of
    any copyright works not owned by you.

    Please Read the Manuscript Submission Guidelines below before submitting your manuscript here:
    SUBMIT MANUSCRIPT

    1. Open Access
    2. Article processing charge (APC)
    3. What do we publish?
      3.1 Aims & scope
      3.2 Article types
      3.3 Writing your paper
      3.3.1 Making your article discoverable 
    4. Editorial policies
      4.1 Peer Review Policy
      4.2 Authorship
      4.3 Acknowledgements
      4.3.1 Writing assistance
      4.4 Funding
      4.5 Declaration of conflicting interests
      4.6 Research ethics and patient consent
      4.7 Clinical Trials
      4.8 Reporting guidelines
      4.9 Data
    5. Publishing policies
      5.1 Publication ethics
      5.2 Contributor's publishing agreement
    6. Preparing your manuscript
      6.1 Word processing formats
      6.2 Artwork, figures and other graphics
      6.3 Supplementary material
      6.4 Reference style
      6.5 English language editing services
    7. Submitting your manuscript
      7.1 How to submit your manuscript
      7.2 Title, keywords and abstracts
      7.3 Information required for completing your submission
      7.4 ORCID
      7.5 Permissions
    8. On acceptance and publication
      8.1 SAGE Production
      8.2 Continuous publication
      8.3 Promoting your article
    9. Further information

    1. Open Access

    Clinical and Applied Thrombosis/Hemostasis is an open access, peer-reviewed journal. Each article
    accepted by peer review is made freely available online immediately upon publication, is published
    under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the
    journal are covered by the collection of article processing charges which are paid by the funder,
    institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to
    the journal.

    For general information on open access at SAGE please visit the Open Access page or view our Open
    Access FAQs
    .

    Back to top

    2. Article processing charge (APC)

    If, after peer review, your manuscript is accepted for publication, a one-time article processing charge
    (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely
    available online in perpetuity under a Creative Commons licence.

    A discounted introductory article processing charge (APC) of $1000 is available for a limited time.

    Back to top

    3. What do we publish?

    3.1 Aims & scope

    Before submitting your manuscript to Clinical and Applied Thrombosis/Hemostasis, please
    ensure you have read the Aims & Scope.

    3.2 Article types

    • Original Manuscripts
    • Reviews
    • Letters to the Editor
    • Editorials
    • Supplemental Article
    • Book Review

    Authors are encouraged to submit review/original manuscripts that are not under consideration
    for publication elsewhere to the Journal for review.

    Manuscript Preparation. Manuscripts should be double-spaced with one-inch margins.
    Headings must be used to designate the major divisions of the paper. Pages should be
    numbered consecutively at the top of the manuscript. The surname of each author should
    appear in the upper left corner of each page, followed by a brief running title.

    Title Page. Page 1 should include the title followed by the names and degrees of all authors as
    they will appear in print. This will be followed by a listing of the authors’ institutional affiliations.
    The title page should also include the name, address, telephone number, e-mail, and fax
    number of the corresponding author, and e-mail addresses for all co-authors. The author should
    cite if the paper was presented orally at a professional meeting, including the name of the
    meeting, date, and place. Credits and grant information supporting the research should also be
    listed if this study was supported by an agency.

    Abstract. The abstract should appear at the beginning of the manuscript and should be no
    longer than 180 words in length. It should summarize the main points of the paper and be
    descriptive, narrative, and informative.

    Tables. Tables should be double-spaced on pages separate from the text. Number tables
    consecutively with text and provide a table number and title for each. Hold length to one
    standard-sized manuscript page if possible. If a table continues past one page, repeat all heads
    and stub (left-hand) column. Tables should be numbered in order of citation in the text. Do not
    use photocopy reduction. Data in tables should not duplicate material in the text or illustrations.
    It is suggested to have no more than 3 tables and 5 figures.

    Artwork. Figure files must be submitted as separate files and are not to be embedded within the
    text file. Please use the following specifications for electronic figures:

    • Authors are encouraged to use Adobe Illustrator and Adobe Photoshop to create
      graphics.
    • Do not use Powerpoint or CorelDRAW. They print poorly on high-density printers.
      JPEG and TIFF files are preferred.
    • The resolution for print must be at least 300 CPI. Low-resolution graphics cannot be
      published.

    References. Please visit the official website of the U.S. National Library of Medicine
    http://www.nlm.nih.gov/bsd/uniform_requirements.html to see how references should be
    listed.

    3.3 Writing your paper

    The SAGE Author Gateway has some general advice and on how to get published, plus links to
    further resources.

    3.3.1 Making your article discoverable 

    When writing up your paper, think about how you can make it discoverable. The title,
    keywords and abstract are key to ensuring readers find your article through search
    engines such as Google. For information and guidance on how best to title your article,
    write your abstract and select your keywords, have a look at this page on the Gateway:
    How to Help Readers Find Your Article Online

    Back to top

    4. Editorial policies

    4.1 Peer review policy

    The journal’s policy is to have manuscripts reviewed by two expert reviewers. Clinical and
    Applied Thrombosis/Hemostasis utilizes a single-blind peer review process in which the
    reviewer’s name and information is withheld from the author. All manuscripts are reviewed as
    rapidly as possible, while maintaining rigor. Reviewers make comments to the author and
    recommendations to the Editor-in-Chief who then makes the final decision.

    As part of the submission process you will be asked to provide the names of 2 peers who could
    be called upon to review your manuscript. Recommended reviewers should be experts in their
    fields and should be able to provide an objective assessment of the manuscript. Please be aware
    of any conflicts of interest when recommending reviewers. Examples of conflicts of interest
    include (but are not limited to) the below:

    • The reviewer should have no prior knowledge of your submission
    • The reviewer should not have recently collaborated with any of the authors
    • Reviewer nominees from the same institution as any of the authors are not permitted

    You will also be asked to nominate peers who you do not wish to review your manuscript
    (opposed reviewers).

    Please note that the Editors are not obliged to invite any recommended/opposed reviewers to
    assess your manuscript.

    The Editor or members of the Editorial Board may occasionally submit their own manuscripts forpossible publication in the journal. In these cases, the peer review process will be managed by
    alternative members of the Board and the submitting Editor / Board member will have no
    involvement in the decision-making process.

    The Editor or members of the Editorial Board may occasionally submit their own manuscripts for
    possible publication in the journal. In these cases, the peer review process will be managed by
    alternative members of the Board and the submitting Editor/Board member will have no
    involvement in the decision-making process.

    4.2 Authorship

    Papers should only be submitted for consideration once consent is given by all contributing
    authors. Those submitting papers should carefully check that all those whose work contributed
    to the paper are acknowledged as contributing authors.
    The list of authors should include all those who can legitimately claim authorship. This is all
    those who:

    (i) Made a substantial contribution to the concept or design of the work; or acquisition,
    analysis or interpretation of data,
    (ii) Drafted the article or revised it critically for important intellectual content,
    (iii) Approved the version to be published,
    (iv) Each author should have participated sufficiently in the work to take public
    responsibility for appropriate portions of the content.

    Authors should meet the conditions of all of the points above. Each author should have
    participated sufficiently in the work to take public responsibility for appropriate portions of the
    content.

    When a large, multicentre group has conducted the work, the group should identify the
    individuals who accept direct responsibility for the manuscript. These individuals should fully
    meet the criteria for authorship.

    Acquisition of funding, collection of data, or general supervision of the research group alone
    does not constitute authorship, although all contributors who do not meet the criteria for
    authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on
    authorship.

    4.3 Acknowledgements

    All contributors who do not meet the criteria for authorship should be listed in an
    Acknowledgements section. Examples of those who might be acknowledged include a person
    who provided purely technical help, or a department chair who provided only general support. 

    4.3.1 Writing assistance

    Individuals who provided writing assistance, e.g. from a specialist communications company, do
    not qualify as authors and so should be included in the Acknowledgements section. Authors
    must disclose any writing assistance – including the individual’s name, company and level of
    input – and identify the entity that paid for this assistance.
    It is not necessary to disclose use of language polishing services.

    Any acknowledgements should appear first at the end of your article prior to your Declaration of
    Conflicting Interests (if applicable), any notes and your References.

    4.4 Funding

    Clinical and Applied Thrombosis/Hemostasis requires all authors to acknowledge their funding in
    a consistent fashion under a separate heading. Please visit the Funding Acknowledgements
    page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in
    the event of funding, or state that: This research received no specific grant from any funding
    agency in the public, commercial, or not-for-profit sectors.

    4.5 Declaration of conflicting interests

    It is the policy of Clinical and Applied Thrombosis/Hemostasis to require a declaration of
    conflicting interests from all authors enabling a statement to be carried within the paginated
    pages of all published articles.

    Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of
    your manuscript, after any acknowledgements and prior to the references. If no conflict exists,
    please state that ‘The Author(s) declare(s) that there is no conflict of interest’.

    For guidance on conflict of interest statements, please see the ICMJE recommendations.

    4.6 Research ethics and patient consent

    Medical research involving human subjects must be conducted according to the World Medical
    Association Declaration of Helsinki
    .

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct,
    Reporting, Editing, and Publication of Scholarly Work in Medical Journals
    , and all papers
    reporting animal and/or human studies must state in the methods section that the relevant
    Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure
    that you have provided the full name and institution of the review committee, in addition to the
    approval number.

    For research articles, authors are also required to state in the methods section whether
    participants provided informed consent and whether the consent was written or verbal.

    Information on informed consent to report individual cases or case series should be included in
    the manuscript text. A statement is required regarding whether written informed consent for
    patient information and images to be published was provided by the patient(s) or a legally
    authorized representative.

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants

    All research involving animals submitted for publication must be approved by an ethics
    committee with oversight of the facility in which the studies were conducted. The journal has
    adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals
    published by the International Association of Veterinary Editors.

    4.7 Clinical trials

    Clinical and Applied Thrombosis/Hemostasis endorses the ICMJE requirement that clinical trials
    are registered in a WHO-approved public trials registry at or before the time of first patient
    enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will
    be considered if the justification for late registration is acceptable. The trial registry name and
    URL, and registration number must be included at the end of the abstract.

    4.8 Reporting guidelines

    The relevant EQUATOR Network reporting guidelines should be followed depending on the type
    of study. For example, all randomized controlled trials submitted for publication should include
    a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should
    be uploaded with your submission as a supplementary file. Systematic reviews and metaanalyses
    should include the completed PRISMA flow chart as a cited figure and the completed
    PRISMA checklist should be uploaded with your submission as a supplementary file. The
    EQUATOR wizard can help you identify the appropriate guideline.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.

    4.9 Data 

    Clinical and Applied Thrombosis/Hemostasis requests all authors submitting any primary data used in their research articles alongside their article submissions to be published in the online version of the journal, or provide detailed information in their articles on how the data can be obtained. This information should include links to third-party data repositories or detailed contact information for third-party data sources. Data available only on an author-maintained website will need to be loaded onto either the journal’s platform or a third-party platform to ensure continuing accessibility. Examples of data types include but are not limited to statistical data files, replication code, text files, audio files, images, videos, appendices, and additional charts and graphs necessary to understand the original research. The editor can also grant exceptions for data that cannot legally or ethically be released. All data submitted should comply with Institutional or Ethical Review Board requirements and applicable government regulations. For further information, please contact the editorial office at sheilaplatt@optonline.net.

    Back to top

    5. Publishing policies

    5.1 Publication ethics

    SAGE is committed to upholding the integrity of the academic record. We encourage authors to
    refer to the Committee on Publication Ethics’ International Standards for Authors and view the
    Publication Ethics page on the SAGE Author Gateway.

    5.1.1 Plagiarism

    Clinical and Applied Thrombosis/Hemostasis and SAGE take issues of copyright infringement,
    plagiarism or other breaches of best practice in publication very seriously. We seek to protect
    the rights of our authors and we always investigate claims of plagiarism or misuse of published
    articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted
    articles may be checked with duplication-checking software. Where an article, for example, is
    found to have plagiarized other work or included third-party copyright material without
    permission or with insufficient acknowledgement, or where the authorship of the article is
    contested, we reserve the right to take action including, but not limited to: publishing an
    erratum or corrigendum (correction); retracting the article; taking up the matter with the head
    of department or dean of the author's institution and/or relevant academic bodies or societies;
    or taking appropriate legal action.

    5.1.2 Prior publication

    If material has been previously published, it is not generally acceptable for publication in a SAGE
    journal. However, there are certain circumstances where previously published material can be
    considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in
    doubt, contact the Editor at the address given below.

    5.2 Contributor's publishing agreement

    Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s
    Publishing Agreement. Clinical and Applied Thrombosis/Hemostasis publishes manuscripts
    under Creative Commons licenses. The standard license for the journal is Creative Commons by
    Attribution Non-Commercial (CC BY-NC), which allows others to re-use the work without
    permission as long as the work is properly referenced and the use is non-commercial. For more
    information, you are advised to visit SAGE's OA licenses page.

    Alternative license arrangements are available, for example, to meet particular funder
    mandates, made at the author’s request. 

    Back to top

    6. Preparing your manuscript

    6.1 Word processing formats

    The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and
    (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author
    Gateway.

    6.2 Artwork, figures and other graphics

    For guidance on the preparation of illustrations, pictures and graphs in electronic format, please
    visit SAGE’s Manuscript Submission Guidelines.

    Figures supplied in color will appear in color online.

    6.3 Supplementary material

    This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images
    etc) alongside the full-text of the article. These will be subjected to peer-review alongside the
    article. For more information please refer to our guidelines on submitting supplementary files,
    which can be found within our Manuscript Submission Guidelines page. 

    6.4 Reference style

    Clinical and Applied Thrombosis/Hemostasis adheres to the American Medical Association
    Manual of Style (9th Edition) for references. Key the references (double spaced) at the end of
    the manuscript. Cite the references in text in the order of appearance. Cite unpublished data,
    such as papers submitted but not yet accepted for publication or personal communications, in
    parentheses in the text. If there are more than three authors, name only the first three authors
    and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of
    journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html.

    6.5 English language editing services

    Authors seeking assistance with English language editing, translation, or figure and manuscript
    formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit
    SAGE Language Services on our Journal Author Gateway for further information. 

    Back to top

    7. Submitting your manuscript

    7.1 How to submit your manuscript

    Clinical and Applied Thrombosis/Hemostasis is hosted on SAGE Track, a web based online
    submission and peer review system powered by ScholarOne™ Manuscripts. Visit
    https://mc.manuscriptcentral.com/cath to login and submit your article online.

    IMPORTANT: Please check whether you already have an account in the system before trying to
    create a new one. If you have reviewed or authored for the journal in the past year it is likely
    that you will have had an account created. For further guidance on submitting your manuscript
    online please visit ScholarOne Online Help.

    7.2 Title, keywords and abstracts

    Please supply a title, short title, an abstract and keywords to accompany your article. The title,
    keywords and abstract are key to ensuring readers find your article online through online search
    engines such as Google. Please refer to the information and guidance on how best to title your
    article, write your abstract and select your keywords by visiting the SAGE Journal Author
    Gateway for guidelines on How to Help Readers Find Your Article Online

    7.3 Information required for completing your submission

    Provide full contact details for the corresponding author including email, mailing address and
    telephone numbers. Academic affiliations are required for all co-authors. These details should
    be presented separately to the main text of the article to facilitate anonymous peer review.

    You will be asked to provide contact details and academic affiliations for all co-authors via the
    submission system and identify who is to be the corresponding author. These details must
    match what appears on your manuscript. At this stage please ensure you have included all the
    required statements and declarations and uploaded any additional supplementary files
    (including reporting guidelines where relevant).

    7.4 ORCID

    As part of our commitment to ensuring an ethical, transparent and fair peer review process
    SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID
    provides a persistent digital identifier that distinguishes researchers from every other researcher
    and, through integration in key research workflows such as manuscript and grant submission,
    supports automated linkages between researchers and their professional activities ensuring that
    their work is recognized.

    We encourage all authors to add their ORCIDs to their SAGE Track accounts and include their
    ORCIDs as part of the submission process. If you don’t already have one you can create one
    here.

    7.5 Permissions

    Authors are responsible for obtaining permission from copyright holders for reproducing any
    illustrations, tables, figures or lengthy quotations previously published elsewhere. For further
    information including guidance on fair dealing for criticism and review, please visit our
    Frequently Asked Questions on the SAGE Journal Author Gateway.

    Back to top

    8. On acceptance and publication

    If your paper is accepted for publication after peer review, you will first be asked to complete the
    contributor’s publishing agreement. Once your manuscript files have been check for SAGE Production,
    the corresponding author will be asked to pay the article processing charge (APC) via a payment link.
    Once the APC has been processed, your article will be prepared for publication and can appear online
    within an average of 30 days. Please note that no production work will occur on your paper until the
    APC has been received.

    8.1 SAGE Production

    Your SAGE Production Editor will keep you informed as to your article’s progress throughout the
    production process. Proofs will be sent by PDF to the corresponding author and should be
    returned promptly. Authors are reminded to check their proofs carefully to confirm that all
    author information, including names, affiliations, sequence and contact details are correct, and
    that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there
    are any changes to the author list at this stage all authors will be required to complete and sign
    a form authorizing the change.

    8.2 Online publication

    One of the many benefits of publishing your research in an open access journal is the speed to
    publication. With no page count constraints, your article will be published online in a fully
    citable form with a DOI number as soon as it has completed the production process. At this time
    it will be completely free to view and download for all. 

    8.3 Promoting your article

    Publication is not the end of the process! You can help disseminate your paper and ensure it is
    as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help
    you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.
    In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich,
    share, and measure the impact of their article. Find out how to maximize your article’s impact
    with Kudos

    Back to top

    9. Further information

    Any correspondence, queries or additional requests for information on the Manuscript Submission
    process should be sent to the Clinical and Applied Thrombosis/Hemostasis editorial office as follows:

    sheilaplatt@optonline.net

    Back to top

     

    Institutional Backfile Purchase, E-access (Content through 1998)